Genome-scale analysis identifies GJB2 and ERO1LB as prognosis markers in patients with pancreatic cancer

Pancreatic cancer is a complex and heterogeneous disease with the etiology largely unknown. The deadly nature of pancreatic cancer, with an extremely low 5-year survival rate, renders urgent a better understanding of the molecular events underlying it. The aim of this study is to investigate the gen...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Tao, Gao, Yuan-Feng, Chen, Yi-Xin, Wang, Zhi-Bin, Yin, Ji-Ye, Mao, Xiao-Yuan, Li, Xi, Zhang, Wei, Zhou, Hong-Hao, Liu, Zhao-Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400583/
https://www.ncbi.nlm.nih.gov/pubmed/28177904
http://dx.doi.org/10.18632/oncotarget.15068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5400583/
https://www.ncbi.nlm.nih.gov/pubmed/28177904
http://dx.doi.org/10.18632/oncotarget.15068

Ejemplares similares